NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 146 filers reported holding NEVRO CORP in Q4 2023. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $327,104 | +394001.2% | 15,200 | +253.5% | 0.00% | +100.0% |
| Q3 2023 | $83 | -36.2% | 4,300 | -15.7% | 0.00% | 0.0% |
| Q2 2023 | $130 | +2.4% | 5,100 | +45.7% | 0.00% | 0.0% |
| Q1 2023 | $127 | -100.0% | 3,500 | -65.1% | 0.00% | -66.7% |
| Q2 2022 | $439,000 | +3.5% | 10,015 | +70.9% | 0.00% | +50.0% |
| Q1 2022 | $424,000 | -41.1% | 5,860 | -33.2% | 0.00% | -50.0% |
| Q4 2021 | $720,000 | -29.5% | 8,769 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,021,000 | -16.8% | 8,769 | +18.5% | 0.01% | -25.0% |
| Q2 2021 | $1,227,000 | +22.3% | 7,401 | +2.9% | 0.01% | +14.3% |
| Q1 2021 | $1,003,000 | -10.9% | 7,193 | +10.6% | 0.01% | -12.5% |
| Q4 2020 | $1,126,000 | +46.2% | 6,505 | +17.6% | 0.01% | +33.3% |
| Q3 2020 | $770,000 | +5033.3% | 5,530 | +4324.0% | 0.01% | – |
| Q2 2020 | $15,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $45,155,275 | 1.48% |
| ARMISTICE CAPITAL, LLC | 2,356,000 | $59,889,520 | 0.87% |
| Rock Springs Capital Management LP | 1,211,400 | $30,793,788 | 0.73% |
| ArrowMark Colorado Holdings LLC | 1,817,189 | $46,192,944 | 0.51% |
| Palo Alto Investors LP | 186,259 | $4,734,704 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 51,000 | $1,296,420 | 0.30% |
| TD Capital Management LLC | 84,648 | $2,151,752 | 0.26% |
| Point72 Europe (London) LLP | 73,800 | $1,875,996 | 0.25% |
| Venator Management LLC | 25,000 | $636 | 0.23% |
| Virtus Investment Advisers, Inc. | 12,500 | $317,750 | 0.22% |